Skip to main content

Table 1 Characteristics of population

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

  Dose Level
  300 mg/m2 400 mg/m2 500 mg/m2
No. of patients 3 3 23
Age (years)    
   Mean 68 50 58
   Range 63–75 42–62 40–75
Sex    
   Male 3 1 17
   Female 0 2 6
Karnofsky Performance Status    
   100% 2 1 9
   90% 0 1 7
   80% 1 1 7
Clinical stage    
   cT2cN3 0 0 2
   cT3cN2 2 0 1
   cT3cN3 0 0 6
   cT4 cN0 0 0 6
   cT4 cN2 0 2 5
   cT4 cN3 1 1 3
Histology    
   Adenocarcinoma 0 2 6
   Squamous Carcinoma 1 1 15
   Adenosquamous Carcinoma 1 0 1
   Large-Cell Carcinoma 1 0 1